NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $62.2 million in its third quarter.
The New York-based company said it had a loss of $1.32 per share.
The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share.
The biopharmaceutical company posted revenue of $57.8 million in the period, which topped Street forecasts. Seven analysts surveyed by Zacks expected $54.9 million.
Axsome shares have declined 16% since the beginning of the year. The stock has climbed 14% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXSM at https://www.zacks.com/ap/AXSM